Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

TNF-alpha inhibitors can cause various immune-related skin issues.

People with alopecia areata often have thyroid autoimmunity.

Deep learning helps detect skin conditions and is advancing dermatology diagnosis and treatment.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

The document discusses various challenging skin conditions and their treatments.

Blue light might help treat skin conditions by affecting the skin's bacteria.

Doctors should consider Netherton syndrome in patients with chronic skin and hair issues to avoid misdiagnosis.

Kidney transplant patients often have skin issues, mainly infections.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

No cure exists for alopecia areata, and treatments are personalized.

Accurate diagnosis and tailored treatments are crucial for managing hair loss in humans and animals.

The document concludes that various topical medications are effective for skin conditions but often cause skin irritation as a side effect.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

The model and estimator can predict drug exposure in kidney transplant patients well.

The document covers various dermatological conditions and their studies.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.